TerminatedPhase 1NCT01014546

Arsenic Trioxide With or Without Ascorbic Acid in Treating Patients With Myelofibrosis

Studying Essential thrombocythemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Roswell Park Cancer Institute
Principal Investigator
Eunice Wang, MD
Roswell Park Cancer Institute
Intervention
Arsenic Trioxide(drug)
Enrollment
5 enrolled
Eligibility
19 years · All sexes
Timeline
2010 – 2015

Study locations (1)

Collaborators

Cephalon, Inc.

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01014546 on ClinicalTrials.gov

Other trials for Essential thrombocythemia

Additional recruiting or active studies for the same condition.

See all trials for Essential thrombocythemia →

← Back to all trials